BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nagy F, Molnár T, Szepes Z, Farkas K, Nyári T, Lonovics J. Efficacy of 6-mercaptopurine treatment after azathioprine hypersensitivity in inflammatory bowel disease. World J Gastroenterol 2008; 14(27): 4342-4346 [PMID: 18666323 DOI: 10.3748/wjg.14.4342]
URL: https://www.wjgnet.com/1007-9327/full/v14/i27/4342.htm
Number Citing Articles
1
Henrik Hjortswang. The Kock Pouch2019; : 143 doi: 10.1007/978-3-319-95591-9_15
2
Jaimin Amin, Brian Huang, Jessica Yoon, David Q. Shih. Update 2014Inflammatory Bowel Diseases 2015; 21(2): 445 doi: 10.1097/MIB.0000000000000197
3
Sarah Healy, Kariem Tarik Elhadd, Emily Gibbons, Dan Whittam, Michael Griffiths, Anu Jacob, Saif Huda. Treatment of myelin oligodendrocyte glycoprotein immunoglobulin G–associated diseaseClinical and Experimental Neuroimmunology 2021; 12(1): 22 doi: 10.1111/cen3.12630
4
Jihye Park, Jae Hee Cheon. Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-αThe Korean Journal of Internal Medicine 2022; 37(5): 895 doi: 10.3904/kjim.2022.132
5
Arthur Turow, Tuck Y Yong, Jie Shen Fok, Jordan YZ Li. Azathioprine Hypersensitivity Presenting as Cardiogenic Shock and Sweet's Syndrome in a Patient with Microscopic PolyangiitisInternal Medicine 2012; 51(14): 1889 doi: 10.2169/internalmedicine.51.6962
6
A. Dignass, G. Van Assche, J.O. Lindsay, M. Lémann, J. Söderholm, J.F. Colombel, S. Danese, A. D'Hoore, M. Gassull, F. Gomollón, D.W. Hommes, P. Michetti, C. O'Morain, T. Öresland, A. Windsor, E.F. Stange, S.P.L. Travis. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current managementJournal of Crohn's and Colitis 2010; 4(1): 28 doi: 10.1016/j.crohns.2009.12.002
7
Byong Duk Ye, Suk-Kyun Yang, Sung Jae Shin, Kang Moon Lee, Byung Ik Jang, Jae Hee Cheon, Chang Hwan Choi, Young-Ho Kim, Heeyoung Lee. Guidelines for the Management of Crohn's DiseaseThe Korean Journal of Gastroenterology 2012; 59(2): 141 doi: 10.4166/kjg.2012.59.2.141
8
Adi Lahat, Rami Eliakim. Crohn's Disease and Ulcerative Colitis2017; : 321 doi: 10.1007/978-3-319-33703-6_30
9
Robin J. Dart, Peter M. Irving. Optimising use of thiopurines in inflammatory bowel diseaseExpert Review of Clinical Immunology 2017; 13(9): 877 doi: 10.1080/1744666X.2017.1351298
10
Somnath Mookherjee, Maya Narayanan, Tomoharu Uchiyama, Kelly L. Wentworth. Three Hospital Admissions in 9 Days to Diagnose Azathioprine Hypersensitivity in a Patient With Crohn's DiseaseAmerican Journal of Therapeutics 2015; 22(2): e28 doi: 10.1097/MJT.0b013e318296f153
11
Byong Duk Ye, Suk-Kyun Yang, Sung Jae Shin, Kang Moon Lee, Byung Ik Jang, Jae Hee Cheon, Chang Hwan Choi, Young-Ho Kim, Heeyoung Lee. Guidelines for the Management of Crohn's DiseaseIntestinal Research 2012; 10(1): 26 doi: 10.5217/ir.2012.10.1.26
12
Bipadabhanjan Mallick, Sarthak Malik. Use of Azathioprine in Ulcerative Colitis: A Comprehensive ReviewCureus 2022;  doi: 10.7759/cureus.24874
13
J.K. Aronson. A worldwide yearly survey of new data in adverse drug reactionsSide Effects of Drugs Annual 2011; 33: 815 doi: 10.1016/B978-0-444-53741-6.00038-6
14
Mauro Pagani. The Complex Clinical Picture of Presumably Allergic Side Effects to Cytostatic Drugs: Symptoms, Pathomechanism, Reexposure, and DesensitizationMedical Clinics of North America 2010; 94(4): 835 doi: 10.1016/j.mcna.2010.03.002
15
Motoaki Kuriyama, Jun Kato, Hideyuki Suzuki, Mitsuhiro Akita, Sakiko Hiraoka, Hiroyuki Okada, Kazuhide Yamamoto. TOLERABILITY AND USEFULNESS OF MERCAPTOPURINE IN AZATHIOPRINE‐INTOLERANT JAPANESE PATIENTS WITH ULCERATIVE COLITISDigestive Endoscopy 2010; 22(4): 289 doi: 10.1111/j.1443-1661.2010.01009.x
16
Sherry Yang, Chauncey McHargue. An asymptomatic papulopustular eruption in an immunosuppressed patientInternational Journal of Dermatology 2014; 53(11): 1303 doi: 10.1111/ijd.12653
17
Huma Hameed, Khurram Rehman, Anam Hameed, Abdul Qayuum. Preparation and characterization of pH-responsive ionic crosslinked microparticles of mercaptopurine to target ulcerative colitisPolymers and Polymer Composites 2021; 29(9_suppl): S1248 doi: 10.1177/09673911211047338
18
Rishi M. Goel, Paul Blaker, Alex Mentzer, Steven C.M. Fong, Anthony M. Marinaki, Jeremy D. Sanderson. Optimizing the use of thiopurines in inflammatory bowel diseaseTherapeutic Advances in Chronic Disease 2015; 6(3): 138 doi: 10.1177/2040622315579063
19
N. A. Kennedy, E. Rhatigan, I. D. R. Arnott, C. L. Noble, A. G. Shand, J. Satsangi, C. W. Lees. A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta‐analysisAlimentary Pharmacology & Therapeutics 2013; 38(10): 1255 doi: 10.1111/apt.12511